Loading...
XJPX
4202
Market cap2.20bUSD
Jul 09, Last price  
1,400.50JPY
1D
-0.43%
1Q
10.10%
Jan 2017
8.57%
Name

Daicel Corp

Chart & Performance

D1W1MN
XJPX:4202 chart
P/E
35.13
P/S
0.62
EPS
39.86
Div Yield, %
4.28%
Shrs. gr., 5y
-2.77%
Rev. gr., 5y
8.05%
Revenues
579.63b
-1.18%
381,422,000,000416,989,000,000377,979,000,000320,243,000,000353,684,000,000341,942,000,000358,513,000,000413,786,000,000443,775,000,000449,878,000,000440,061,000,000462,956,000,000464,859,000,000412,826,000,000393,568,000,000467,937,000,000538,026,000,000558,056,000,000586,531,000,000579,629,000,000
Net income
10.18b
-79.42%
17,438,000,00013,675,000,0001,296,000,00011,069,000,00016,802,000,00011,827,000,00015,372,000,00022,843,000,00031,252,000,00040,313,000,00043,198,000,00037,062,000,00035,302,000,0004,978,000,00019,713,000,00031,254,000,00040,683,000,00055,835,000,00049,481,000,00010,181,000,000
CFO
67.84b
-27.37%
25,534,000,00049,275,000,00040,165,000,00066,445,000,00053,428,000,00034,000,000,00044,480,000,00044,777,000,00057,412,000,00065,419,000,00086,168,000,00066,888,000,00058,523,000,00057,193,000,00057,869,000,00042,993,000,00026,847,000,00076,729,000,00093,406,000,00067,838,000,000
Dividend
Sep 29, 202635 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Daicel Corporation, a globally active company founded in Osaka, Japan, in 1919, operates across diverse sectors including medical/healthcare, smart technologies, safety solutions, advanced materials, and engineering plastics. Its extensive product range serves various industries across Japan, China, and international markets. The company provides cosmetic ingredients like 1,3-Butylene glycol and polyglycerin, alongside specialized chiral and achiral columns, analytical tools, reagents, and comprehensive services for analysis, purification, and synthesis. For the electronics industry, Daicel offers high-performance films, solvents for electronic materials, resist polymers, semiconductor cleaning agents, optical components, silver nanoparticle inks, and organic semiconductor devices. In safety applications, their portfolio includes inflators, pyro-fuses, and safety devices designed for non-mobility products. They also manufacture a wide array of chemical products such as acetic acid and its derivatives, cellulose acetate, cycloaliphatic epoxies, and caprolactone. Additionally, Daicel contributes to the health and wellness sector with nutraceuticals like ceramide from konjac root, equol from soybeans, and specialized supplement formulations such as DiSPERZiSTA. Their offerings further encompass engineering plastics, high-performance polymers, functional sheets, and packaging films, alongside advanced water treatment systems like UF membrane modules and ultra-fine bubble diffusers. These innovative products are vital for applications in transportation, electronics, medical care, personal care, daily life, and environmental and energy management. Formerly known as Daicel Chemical Industries, Ltd., the company adopted its current name in October 2011.
IPO date
May 16, 1949
Employees
11,207
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT